Related Experiment Video
Updated: Jul 17, 2026

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
Published on: June 2, 2016
Caspase-3 antisense oligodeoxynucleotides inhibit apoptosis in gamma-irradiated human leukemia HL-60 cells
Xiao-Tian Zhang1, Tian-Bao Song, Bao-Ling Du
1Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Department of Human Anatomy and Histology-Embryology, School of Medicine, Xi'an Jiaotong University, Xi'an, Shannxi, 710061, China.
Abstract:
To study the inhibitory effects of caspase-3 mRNA antisense oligodeoxynucleotides (ASODNs) on apoptosis, we designed four ASODNs targeting different regions of caspase-3 mRNA and transfected them into human leukemia HL-60 cells. The transfected cells were given 10 Gy gamma-irradiation followed by incubation for 18 h and measurement of apoptosis and caspase-3 expression. Our results showed that ASODN-2 targeting the 5' non-coding region of sites -62 to -46, and ASODN-3 targeting the 5' coding region of sites -1 to 16, both reduced apoptosis measured by gel electrophoresis and flow cytometry. Hoechst 33258 staining and TUNEL assay revealed that apoptotic indexes in the ASODN-2 and ASODN-3 groups were significantly lower than those in the untransfected and mismatched oligodeoxynucleotide (MODN) groups. Immunocytochemistry, Western blotting and RT-PCR showed that expression levels of caspase-3 protein and mRNA in both ASODN-2 and ASODN-3 groups were decreased compared with those in the untransfected and MODN groups. In conclusion, caspase-3 mRNA ASODNs can inhibit gamma-radiation-induced apoptosis of HL-60 cells and reduce expression of caspase-3 protein and mRNA. The results suggest that antisense approach may be useful for therapeutic treatment of certain neurodegenerative diseases in which apoptosis is involved.
Insights
Antisense oligodeoxynucleotides targeting caspase-3 mRNA effectively inhibited apoptosis in human leukemia cells induced by gamma radiation. This suggests a potential therapeutic strategy for diseases involving programmed cell death.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Apoptosis, or programmed cell death, is a critical cellular process implicated in various diseases.
- Caspase-3 is a key executioner enzyme in the apoptotic pathway.
- Antisense oligodeoxynucleotides (ASODNs) offer a targeted approach to modulate gene expression.
Purpose of the Study:
- To investigate the inhibitory effects of caspase-3 mRNA ASODNs on gamma-radiation-induced apoptosis in human leukemia HL-60 cells.
- To evaluate the impact of ASODNs targeting different regions of caspase-3 mRNA on apoptosis and caspase-3 expression.
- To assess the potential of the antisense approach for therapeutic applications.
Main Methods:
- Transfection of human leukemia HL-60 cells with four distinct ASODNs targeting caspase-3 mRNA.
- Induction of apoptosis using 10 Gy gamma-irradiation.
- Measurement of apoptosis using gel electrophoresis, flow cytometry, Hoechst 33258 staining, and TUNEL assay.
- Assessment of caspase-3 expression at both protein and mRNA levels using immunocytochemistry, Western blotting, and RT-PCR.
Main Results:
- ASODN-2 and ASODN-3 significantly reduced apoptosis compared to untransfected and mismatched oligodeoxynucleotide (MODN) control groups.
- Apoptotic indexes were significantly lower in ASODN-2 and ASODN-3 treated cells.
- Expression levels of caspase-3 protein and mRNA were decreased in cells treated with ASODN-2 and ASODN-3.
Conclusions:
- Caspase-3 mRNA ASODNs effectively inhibit gamma-radiation-induced apoptosis in HL-60 cells.
- The antisense approach targeting caspase-3 mRNA can reduce the expression of both caspase-3 protein and mRNA.
- These findings suggest that antisense therapy may hold promise for treating neurodegenerative diseases characterized by apoptosis.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
